Nicotine metabolite ratio as a predictor of CYP2A6 phenotypic activity.

被引：0
|
作者：
Dempsey, DA [1 ]
Tutka, P [1 ]
Jacob, P [1 ]
Benowitz, NL [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2002年 / 71卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P24 / P24
页数：1
相关论文
共 50 条
  • [31] Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method
    Mwenifumbo, JC
    Myers, MG
    Wall, TL
    Lin, SK
    Sellers, EM
    Tyndale, RF
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (03): : 189 - 192
  • [32] Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme
    Rahnasto, M
    Raunio, H
    Poso, A
    Wittekindt, C
    Juvonen, RO
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) : 440 - 449
  • [33] Artemisinin and CYP2A6 activity in healthy subjects
    Asimus, Sara
    Hai, Trinh Ngoc
    Huong, Nguyen Van
    Ashton, Michael
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (03) : 283 - 292
  • [34] Artemisinin and CYP2A6 activity in healthy subjects
    Sara Asimus
    Trinh Ngoc Hai
    Nguyen Van Huong
    Michael Ashton
    European Journal of Clinical Pharmacology, 2008, 64 : 283 - 292
  • [35] The significance of the homozygous CYP2A6 deletion on nicotine metabolism:: A new genotyping method of CYP2A6 using a single PCR-RFLP
    Kitagawa, K
    Kunugita, N
    Katoh, T
    Yang, MH
    Kawamoto, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 262 (01) : 146 - 151
  • [36] Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism
    Ring, Huijun Z.
    Valdes, Ana M.
    Nishita, Denise M.
    Prasad, Suman
    Jacob, Peyton, III
    Tyndale, Rachel F.
    Swan, Gary E.
    Benowitz, Neal L.
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (12): : 1007 - 1015
  • [37] Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme -: an in silico approach
    Rahnasto, M.
    Wittekindt, C.
    Juvonen, R. O.
    Turpeinen, M.
    Petsalo, A.
    Pelkonen, O.
    Poso, A.
    Stahl, G.
    Holtje, H-D
    Raunio, H.
    PHARMACOGENOMICS JOURNAL, 2008, 8 (05): : 328 - 338
  • [38] Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6
    Nakajima, M
    Kuroiwa, Y
    Yokoi, T
    DRUG METABOLISM REVIEWS, 2002, 34 (04) : 865 - +
  • [39] Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence
    Malaiyandi, V
    Sellers, EM
    Tyndale, RF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (03) : 145 - 158
  • [40] Dissecting the Association of CYP2A6 With Nicotine Metabolism in African American Smokers
    Pouget, Jennie
    El-Boraie, Ahmed
    Lerman, Caryn
    Knight, Jo
    Cox, Lisa S.
    Nollen, Nikki L.
    Ahluwalia, Jasjit S.
    Chenoweth, Meghan J.
    Tyndale, Rachel F.
    BIOLOGICAL PSYCHIATRY, 2022, 91 (09) : S92 - S93
12345